Immunosuppressive activity of tumor-infiltrating myeloid cells in patients with meningioma

Laura Pinton, Samantha Solito, Elena Masetto, Marina Vettore, Stefania Canè, Alessandro Della Puppa, Susanna Mandruzzato

Research output: Contribution to journalArticle

Abstract

Meningiomas WHO grade I and II are common intracranial tumors in adults that normally display a benign outcome, but are characterized by a great clinical heterogeneity and frequent recurrence of the disease. Although the presence of an immune cell infiltrate has been documented in these tumors, a clear phenotypical and functional characterization of the immune web is missing. Here, we performed an extensive immunophenotyping of peripheral blood and fresh tumor tissue at surgery by multiparametric flow cytometry in 34 meningioma patients, along with immunosuppressive activity of sorted cells of myeloid origin. Four subsets of myeloid cells, phenotypically corresponding to myeloid-derived suppressor cells (MDSCs) are detectable in the blood and in the tumor tissue of patients and three of them are significantly expanded in the blood of patients, but show no evidence of suppressive activity. At the tumor site, a large leukocyte infiltrate is present, predominantly constituted by CD33+ myeloid cells, largely composed of macrophages endowed with suppressive activity and significantly expanded in grade II meningioma patients as compared to grade I.

Original languageEnglish
Pages (from-to)e1440931
JournalOncoImmunology
Volume7
Issue number7
DOIs
Publication statusPublished - 2018

Fingerprint

Meningioma
Myeloid Cells
Immunosuppressive Agents
Neoplasms
Immunophenotyping
Flow Cytometry
Leukocytes
Macrophages
Recurrence

Cite this

Immunosuppressive activity of tumor-infiltrating myeloid cells in patients with meningioma. / Pinton, Laura; Solito, Samantha; Masetto, Elena; Vettore, Marina; Canè, Stefania; Puppa, Alessandro Della; Mandruzzato, Susanna.

In: OncoImmunology, Vol. 7, No. 7, 2018, p. e1440931.

Research output: Contribution to journalArticle

Pinton, Laura ; Solito, Samantha ; Masetto, Elena ; Vettore, Marina ; Canè, Stefania ; Puppa, Alessandro Della ; Mandruzzato, Susanna. / Immunosuppressive activity of tumor-infiltrating myeloid cells in patients with meningioma. In: OncoImmunology. 2018 ; Vol. 7, No. 7. pp. e1440931.
@article{81937b7b9379422bb5babdac346a87b8,
title = "Immunosuppressive activity of tumor-infiltrating myeloid cells in patients with meningioma",
abstract = "Meningiomas WHO grade I and II are common intracranial tumors in adults that normally display a benign outcome, but are characterized by a great clinical heterogeneity and frequent recurrence of the disease. Although the presence of an immune cell infiltrate has been documented in these tumors, a clear phenotypical and functional characterization of the immune web is missing. Here, we performed an extensive immunophenotyping of peripheral blood and fresh tumor tissue at surgery by multiparametric flow cytometry in 34 meningioma patients, along with immunosuppressive activity of sorted cells of myeloid origin. Four subsets of myeloid cells, phenotypically corresponding to myeloid-derived suppressor cells (MDSCs) are detectable in the blood and in the tumor tissue of patients and three of them are significantly expanded in the blood of patients, but show no evidence of suppressive activity. At the tumor site, a large leukocyte infiltrate is present, predominantly constituted by CD33+ myeloid cells, largely composed of macrophages endowed with suppressive activity and significantly expanded in grade II meningioma patients as compared to grade I.",
author = "Laura Pinton and Samantha Solito and Elena Masetto and Marina Vettore and Stefania Can{\`e} and Puppa, {Alessandro Della} and Susanna Mandruzzato",
year = "2018",
doi = "10.1080/2162402X.2018.1440931",
language = "English",
volume = "7",
pages = "e1440931",
journal = "OncoImmunology",
issn = "2162-4011",
publisher = "Taylor and Francis Inc.",
number = "7",

}

TY - JOUR

T1 - Immunosuppressive activity of tumor-infiltrating myeloid cells in patients with meningioma

AU - Pinton, Laura

AU - Solito, Samantha

AU - Masetto, Elena

AU - Vettore, Marina

AU - Canè, Stefania

AU - Puppa, Alessandro Della

AU - Mandruzzato, Susanna

PY - 2018

Y1 - 2018

N2 - Meningiomas WHO grade I and II are common intracranial tumors in adults that normally display a benign outcome, but are characterized by a great clinical heterogeneity and frequent recurrence of the disease. Although the presence of an immune cell infiltrate has been documented in these tumors, a clear phenotypical and functional characterization of the immune web is missing. Here, we performed an extensive immunophenotyping of peripheral blood and fresh tumor tissue at surgery by multiparametric flow cytometry in 34 meningioma patients, along with immunosuppressive activity of sorted cells of myeloid origin. Four subsets of myeloid cells, phenotypically corresponding to myeloid-derived suppressor cells (MDSCs) are detectable in the blood and in the tumor tissue of patients and three of them are significantly expanded in the blood of patients, but show no evidence of suppressive activity. At the tumor site, a large leukocyte infiltrate is present, predominantly constituted by CD33+ myeloid cells, largely composed of macrophages endowed with suppressive activity and significantly expanded in grade II meningioma patients as compared to grade I.

AB - Meningiomas WHO grade I and II are common intracranial tumors in adults that normally display a benign outcome, but are characterized by a great clinical heterogeneity and frequent recurrence of the disease. Although the presence of an immune cell infiltrate has been documented in these tumors, a clear phenotypical and functional characterization of the immune web is missing. Here, we performed an extensive immunophenotyping of peripheral blood and fresh tumor tissue at surgery by multiparametric flow cytometry in 34 meningioma patients, along with immunosuppressive activity of sorted cells of myeloid origin. Four subsets of myeloid cells, phenotypically corresponding to myeloid-derived suppressor cells (MDSCs) are detectable in the blood and in the tumor tissue of patients and three of them are significantly expanded in the blood of patients, but show no evidence of suppressive activity. At the tumor site, a large leukocyte infiltrate is present, predominantly constituted by CD33+ myeloid cells, largely composed of macrophages endowed with suppressive activity and significantly expanded in grade II meningioma patients as compared to grade I.

U2 - 10.1080/2162402X.2018.1440931

DO - 10.1080/2162402X.2018.1440931

M3 - Article

C2 - 29900047

VL - 7

SP - e1440931

JO - OncoImmunology

JF - OncoImmunology

SN - 2162-4011

IS - 7

ER -